Ferrieri A - Search Results

1

Intestinal protozoa in HIV-infected patients: effect of rifaximin in Cryptosporidium parvum and Blastocystis hominis infections.

Amenta M, Dalle Nogare ER, Colomba C, Prestileo TS, Di Lorenzo F, Fundaro S, Colomba A, Ferrieri A. Amenta M, et al. Among authors: ferrieri a. J Chemother. 1999 Oct;11(5):391-5. doi: 10.1179/joc.1999.11.5.391. J Chemother. 1999. PMID: 10632386 Clinical Trial.

2

Rifaximin and Helicobacter pylori eradication.

De Giorgio R, Stanghellini V, Barbara G, Guerrini S, Ferrieri A, Corinaldesi R. De Giorgio R, et al. Among authors: ferrieri a. Eur Rev Med Pharmacol Sci. 1997 Jul-Aug;1(4):105-10. Eur Rev Med Pharmacol Sci. 1997. PMID: 9558774 Clinical Trial.

3

Effect of rifaximin on intestinal bacterial overgrowth in Crohn's disease as assessed by the H2-Glucose Breath Test.

Biancone L, Vernia P, Agostini D, Ferrieri A, Pallone F. Biancone L, et al. Among authors: ferrieri a. Curr Med Res Opin. 2000;16(1):14-20. doi: 10.1185/0300799009117003. Curr Med Res Opin. 2000. PMID: 16422030 Clinical Trial.

4

Intestinal bacterial overgrowth during chronic pancreatitis.

Trespi E, Ferrieri A. Trespi E, et al. Among authors: ferrieri a. Curr Med Res Opin. 1999;15(1):47-52. doi: 10.1185/03007999909115173. Curr Med Res Opin. 1999. PMID: 10216811

5

[Clinical-therapeutic considerations in the treatment of aspecific abdominal disturbances in patients with ulcerative colitis in remission: preliminary note on therapy with rifaximin].

Riegler G, Russo MI, Carratù R, Ferrieri A. Riegler G, et al. Among authors: ferrieri a. Riv Eur Sci Med Farmacol. 1992 Feb;14(1):9-14. Riv Eur Sci Med Farmacol. 1992. PMID: 1529151 Italian.

6

Rifaximin in the treatment of chronic hepatic encephalopathy.

Puxeddu A, Quartini M, Massimetti A, Ferrieri A. Puxeddu A, et al. Among authors: ferrieri a. Curr Med Res Opin. 1995;13(5):274-81. doi: 10.1185/03007999509111552. Curr Med Res Opin. 1995. PMID: 7555036 Clinical Trial.

7

Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.

Gionchetti P, Rizzello F, Venturi A, Ugolini F, Rossi M, Brigidi P, Johansson R, Ferrieri A, Poggioli G, Campieri M. Gionchetti P, et al. Among authors: ferrieri a. Aliment Pharmacol Ther. 1999 Jun;13(6):713-8. doi: 10.1046/j.1365-2036.1999.00553.x. Aliment Pharmacol Ther. 1999. PMID: 10383499 Free article.

8

Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth.

Di Stefano M, Malservisi S, Veneto G, Ferrieri A, Corazza GR. Di Stefano M, et al. Among authors: ferrieri a. Aliment Pharmacol Ther. 2000 May;14(5):551-6. doi: 10.1046/j.1365-2036.2000.00751.x. Aliment Pharmacol Ther. 2000. PMID: 10792117 Free article. Clinical Trial.

9

Antibacterial activity of rifaximin reduces the levels of benzodiazepine-like compounds in patients with liver cirrhosis.

Zeneroli ML, Venturini I, Stefanelli S, Farina F, Miglioli RC, Minelli E, Amedei ER, Ferrieri A, Avallone R, Baraldi M. Zeneroli ML, et al. Among authors: ferrieri a. Pharmacol Res. 1997 Jun;35(6):557-60. doi: 10.1006/phrs.1997.0198. Pharmacol Res. 1997. PMID: 9356209

10

Evaluation of rifaximin, placebo and lactulose in reducing the levels of benzodiazepine-like compounds in patients with liver cirrhosis: a pilot study.

Venturini I, Ferrieri A, Farina F, Cosenza F, Avallone R, Corsi L, Baraldi M, Zeneroli ML. Venturini I, et al. Among authors: ferrieri a. Drugs Exp Clin Res. 2005;31(4):161-8. Drugs Exp Clin Res. 2005. PMID: 16223206 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page